276 related articles for article (PubMed ID: 12182969)
1. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.
Warde P; O'Sullivan B; Aslanidis J; Kroll B; Lockwood G; Waldron J; Payne D; Bayley A; Ringash J; Kim J; Liu FF; Maxymiw W; Sprague S; Cummings BJ
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):9-13. PubMed ID: 12182969
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P
J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
LeVeque FG; Montgomery M; Potter D; Zimmer MB; Rieke JW; Steiger BW; Gallagher SC; Muscoplat CC
J Clin Oncol; 1993 Jun; 11(6):1124-31. PubMed ID: 8501499
[TBL] [Abstract][Full Text] [Related]
4. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
5. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia.
Haddad P; Karimi M
Radiother Oncol; 2002 Jul; 64(1):29-32. PubMed ID: 12208571
[TBL] [Abstract][Full Text] [Related]
7. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
Sangthawan D; Watthanaarpornchai S; Phungrassami T
J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
[TBL] [Abstract][Full Text] [Related]
8. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
9. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer.
Gornitsky M; Shenouda G; Sultanem K; Katz H; Hier M; Black M; Velly AM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jul; 98(1):45-52. PubMed ID: 15243470
[TBL] [Abstract][Full Text] [Related]
10. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09.
Fisher J; Scott C; Scarantino CW; Leveque FG; White RL; Rotman M; Hodson DI; Meredith RF; Foote R; Bachman DG; Lee N
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):832-6. PubMed ID: 12788192
[TBL] [Abstract][Full Text] [Related]
11. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
[TBL] [Abstract][Full Text] [Related]
12. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
13. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer.
Taweechaisupapong S; Pesee M; Aromdee C; Laopaiboon M; Khunkitti W
Aust Dent J; 2006 Dec; 51(4):333-7. PubMed ID: 17256309
[TBL] [Abstract][Full Text] [Related]
15. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia.
Zimmerman RP; Mark RJ; Tran LM; Juillard GF
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):571-5. PubMed ID: 9112455
[TBL] [Abstract][Full Text] [Related]
16. Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma.
Hamlar DD; Schuller DE; Gahbauer RA; Buerki RA; Staubus AE; Hall J; Altman JS; Elzinga DJ; Martin MR
Laryngoscope; 1996 Aug; 106(8):972-6. PubMed ID: 8699911
[TBL] [Abstract][Full Text] [Related]
17. Treatment of radiation side effects with oral pilocarpine.
Schuller DE; Stevens P; Clausen KP; Olsen J; Gahbauer R; Martin M
J Surg Oncol; 1989 Dec; 42(4):272-6. PubMed ID: 2687586
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of pilocarpine in postradiation xerostomia.
Greenspan D; Daniels TE
Cancer; 1987 Mar; 59(6):1123-5. PubMed ID: 3815287
[TBL] [Abstract][Full Text] [Related]
19. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775
[TBL] [Abstract][Full Text] [Related]
20. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia.
Ringash J; Warde P; Lockwood G; O'Sullivan B; Waldron J; Cummings B
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1403-7. PubMed ID: 15817343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
